EUVIMEDEUVIMED entdecken
Crossref

A retrospective analysis of secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with recurrent ovarian cancer

Dong Yang iD, Yanbin Zhang, Ping Gong, Feiran Liu, Yale Gan, Wenpei Bai iD

Journal of Obstetrics and Gynaecology Research · 2023

DOI: 10.1111/jog.15673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2023. Verfasst von Dong Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, Beijing Shijitan Hospital Affiliated to the Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Ovarian Epithelial, Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Beijing Hospital Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the effect of secondary cytoreductive surgery (SeCRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancer patients.

Methods

This retrospective study analyzed a prospective database. We collected information of 389 patients who were diagnosed with recurrent epithelial ovarian cancer. All patients underwent SeCRS with or without HIPEC. Overall survival and progression‐free survival (PFS) were used to evaluate the treatment effectiveness.

Results

Of the 389 patients collected, 123 underwent primary or interval cytoreductive surgery at initial treatment and SeCRS at recurrence (Group A), 130 underwent primary or interval cytoreductive surgery at initial and SeCRS plus HIPEC at recurrence (Group B), and 136 underwent primary or interval cytoreductive surgery plus HIPEC at initial and SeCRS plus HIPEC at recurrence (Group C). The median overall survival for Groups A, B, and C were 49.1 months (95% confidence interval [CI]: 47.6–50.5), 56.0 months (95% CI: 54.2–57.7), and 64.4 months (95% CI: 63.1–65.6), respectively. The median PFS for Groups A, B, and C were 13.1 months (95% CI: 12.6–13.5), 15.0 months (95% CI: 14.2–15.7), and 16.8 months (95% CI: 16.1–17.4), respectively. There were no significant difference in incidence and grade of adverse events among groups.

Conclusions

This study suggested that SeCRS plus HIPEC followed by chemotherapy resulted in longer overall survival and PFS than only SeCRS followed by chemotherapy in patients with recurrent ovarian cancer, especially in patients who were treated with repeat HIPEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsCarcinoma, Ovarian EpithelialCytoreduction Surgical ProceduresHyperthermic Intraperitoneal ChemotherapyOvarian NeoplasmsFemaleHumansCombined Modality TherapyHyperthermia, InducedNeoplasm Recurrence, LocalRetrospective StudiesSurvival Rate

Stichwörter der Autor:innen

chemotherapy in GYN cancersepithelial cancer of the ovarysurgery in GYN cancers

Autor:innen und Institutionen

  • Department of Gynaecology and Obstetrics, Beijing Shijitan Hospital Affiliated to the Capital Medical University, Beijing, People's Republic of China.
  • Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital Affiliated to the Capital Medical University, Beijing, People's Republic of China.

ORCID-Profile: Dong Yang, Wenpei Bai

Förderung

  • Beijing Hospital Authority

Zitieren

APA

Yang, D., Zhang, Y., Gong, P., Liu, F., Gan, Y., & Bai, W. (2023). A retrospective analysis of secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with recurrent ovarian cancer. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15673

Vancouver

Yang D, Zhang Y, Gong P, Liu F, Gan Y, Bai W. A retrospective analysis of secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with recurrent ovarian cancer. Journal of Obstetrics and Gynaecology Research. 2023. doi:10.1111/jog.15673

BibTeX
@article{Yang2023,
  author = {Yang, Dong and Zhang, Yanbin and Gong, Ping and Liu, Feiran and Gan, Yale and Bai, Wenpei},
  title = {A retrospective analysis of secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with recurrent ovarian cancer},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2023},
  doi = {10.1111/jog.15673}
}
Kostenlos starten →